Family Medicine · Vincennes, IN
NPI
1528148434
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
700 Willow St, Suite 200
Vincennes, IN, 47591
Phone (812) 885-8040
Groups this clinician bills Medicare through
Medicare paid, 2024
$113K
3,031 services
Medicare patients, 2024
609
Average age 73
Drug cost, 2024
$4.3M
12,575 prescriptions
Company payments, 2025
$361
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jane M Bridges was code 83036 (blood count), 1,425 times for 599 patients. In total Jane M Bridges billed 3,031 services in 14 codes, and Medicare paid $113K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 83036 Blood Count | Office | 1,425 | 599 | $9.49 | $14K |
| 99214 Office E&M - Established | Office | 936 | 519 | $85.13 | $80K |
| 95251 Test - Miscellaneous | Office | 547 | 328 | $24.22 | $13K |
| 99213 Office E&M - Established | Office | 49 | 36 | $62.90 | $3,082 |
| 11719 Nail Procedure | Office | 20 | 16 | $10.51 | $210 |
| 99215 Office E&M - Established | Office | 11 | 11 | $111.75 | $1,229 |
By year: 2022 $137K for 3,456 services; 2023 $123K for 3,210 services; 2024 $113K for 3,031 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 1,425 | 599 | $9.49 | $14K |
Medicare prescription drug claims, 2024
In 2024, the drug Jane M Bridges prescribed most often to Medicare patients was Jardiance (Empagliflozin), with 1,141 prescriptions and refills. In total Jane M Bridges wrote 12,575 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jardiance Empagliflozin | 1,141 | 1,828 | 202 | $1.0M |
| Glimepiride Generic | 876 | 2,167 | 212 | $5,053 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 515 | 1,153 | 139 | $90K |
| Ozempic Semaglutide | 511 | 666 | 91 | $622K |
| Metformin Hcl Generic | 507 | 1,216 | 122 | $3,233 |
| Novolog Flexpen Insulin Aspart | 465 | 966 | 140 | $133K |
| Levothyroxine Sodium Generic | 465 | 1,164 | 109 | $4,474 |
| Humalog Kwikpen U-100 Insulin Lispro | 428 | 971 | 122 | $142K |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 334 | 689 | 98 | $42K |
| Losartan Potassium Generic | 331 | 797 | 78 | $2,386 |
| Pravastatin Sodium Generic | 271 | 709 | 68 | $3,190 |
| Ezetimibe Generic | 242 | 551 | 58 | $4,452 |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 238 | 507 | 61 | $176K |
| Metformin Hcl Er Metformin Hcl | 224 | 629 | 61 | $2,156 |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 221 | 432 | 61 | $91K |
Brand drugs: 5,954 claims; generic drugs: 5,621 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jane M Bridges $361 ($361 in general payments such as food, travel and fees) from 5 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $121.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.